Vivos Therapeutics (VVOS) Capital Expenditures Growth (5y) (2025 - 2026)

Vivos Therapeutics (VVOS) Capital Expenditures Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn
10	Vivos Therapeutics	4.95 Mn	3.15 Mn	2.95 Mn

Download Data